A detailed history of Mission Creek Capital Partners, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Mission Creek Capital Partners, Inc. holds 16,018 shares of ABT stock, worth $1.84 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
16,018
Previous 16,456 2.66%
Holding current value
$1.84 Million
Previous $1.71 Million 6.85%
% of portfolio
0.43%
Previous 0.43%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $43,830 - $51,740
-438 Reduced 2.66%
16,018 $1.83 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $140,014 - $156,291
1,390 Added 9.23%
16,456 $1.71 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $110,834 - $122,411
-1,012 Reduced 6.29%
15,066 $1.71 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $137,629 - $168,470
1,526 Added 10.49%
16,078 $1.77 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $46,905 - $56,278
491 Added 3.49%
14,552 $1.41 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $85,259 - $94,997
846 Added 6.4%
14,061 $1.53 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $165,824 - $195,185
1,712 Added 14.88%
13,215 $1.34 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $39,640 - $46,503
417 Added 3.76%
11,503 $1.26 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $41,800 - $48,396
432 Added 4.05%
11,086 $1.07 Million
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $19,189 - $23,193
188 Added 1.8%
10,654 $1.16 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $22,918 - $27,947
201 Added 1.96%
10,466 $1.24 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $18,484 - $22,633
-160 Reduced 1.53%
10,265 $1.45 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $72,329 - $80,017
-620 Reduced 5.61%
10,425 $1.23 Million
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $126,207 - $148,564
1,193 Added 12.11%
11,045 $1.28 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $11,101 - $13,079
-102 Reduced 1.02%
9,852 $1.18 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $154,665 - $168,540
1,473 Added 17.37%
9,954 $1.09 Million
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $21,077 - $25,596
-230 Reduced 2.64%
8,481 $923,000
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $23,353 - $29,890
-305 Reduced 3.38%
8,711 $796,000
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $20,102 - $29,395
320 Added 3.68%
9,016 $711,000
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $682,722 - $760,030
8,696 New
8,696 $755,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Mission Creek Capital Partners, Inc. Portfolio

Follow Mission Creek Capital Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Creek Capital Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mission Creek Capital Partners, Inc. with notifications on news.